Deep-gray nuclei susceptibility-weighted imaging filtered phase shift in patients with Wilson's disease

Pediatric Research

Volumn 75, Issue 3, 2014, Pages 436-442

  Bai, Xue ^a   Wang, Guangbin ^a   Wu, Lebin ^a   Liu, Yubo ^b   Cui, Li ^c   Shi, Honglu ^a   Guo, Lingfei ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; DATA PROCESSING; FEMALE; GRAY MATTER; HUMAN; IMAGING SYSTEM; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRESCHOOL CHILD; PRIORITY JOURNAL; RED NUCLEUS; SCHOOL CHILD; SUBSTANTIA NIGRA; SUSCEPTIBILITY WEIGHTED IMAGING; THALAMUS; WILSON DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84896867637     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.239     Document Type: Article

References (27)

1. Ferenci P, Steindl-Munda P, Vogel W, et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease. Clin Gastroenterol Hepatol 2005;3:811-8.
2. Faa G, Lisci M, Caria MP, et al. Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease. J Trace Elem Med Biol 2001;15:155-60.
3. Kim JM, Ko SB, Kwon SJ, et al. Ferrous and ferric iron accumulates in the brain of aged Long-Evans Cinnamon rats, an animal model of Wilson's disease. Neurosci Lett 2005;382:143-7.
4. Hayashi M, Fuse S, Endoh D, et al. Accumulation of copper induces DNA strand breaks in brain cells of Long-Evans Cinnamon (LEC) rats, an animal model for human Wilson Disease. Exp Anim 2006;55:419-26.
5. Singh P, Ahluwalia A, Saggar K, Grewal CS. Wilson's disease: MRI features. J Pediatr Neurosci 2011;6:27-8.
6. Jacobs DA, Markowitz CE, Liebeskind DS, Galetta SL. The "double panda sign" in Wilson's disease. Neurology 2003;61:969.
7. Andersen K, Südmeyer M, Saleh A. [Cerebral imaging for Wilson disease]. Rofo 2007;179:225-33.
8. Kim TJ, Kim IO, Kim WS, et al. MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuroradiol 2006;27:1373-8.
9. da Costa Mdo D, Spitz M, Bacheschi LA, Leite CC, Lucato LT, Barbosa ER. Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI. Neuroradiology 2009;51:627-33.
10. Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439-50.
11. Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 2007;26:256-64.
12. Saini S, Frankel RB, Stark DD, Ferrucci JT Jr. Magnetism: a primer and review. AJR Am J Roentgenol 1988;150:735-43.
13. Schenck JF. Magnetic resonance imaging of brain iron. J Neurol Sci 2003;207:99-102.
14. Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009;30:232-52.
15. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-8.
16. Zhu WZ, Zhong WD, Wang W, et al. Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 2009;253:497-504.
17. Jin L, Wang J, Zhao L, et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain 2011;134(Pt 1):50-8.
18. Petrovecki V, Kovacic Z, Pizent A, Jakic-Razumovic J. [Copper levels in the tissues of patients with Wilson's disease]. Arh Hig Rada Toksikol 1997;48:241-6.
19. Sullivan EV, Adalsteinsson E, Rohlfing T, Pfefferbaum A. Relevance of Iron Deposition in Deep Gray Matter Brain Structures to Cognitive and Motor Performance in Healthy Elderly Men and Women: Exploratory Findings. Brain Imaging Behav 2009;3:167-75.
20. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995;92:2539-43.
21. Ranganathan PN, Lu Y, Jiang L, Kim C, Collins JF. Serum ceruloplasmin protein expression and activity increases in iron-deficient rats and is further enhanced by higher dietary copper intake. Blood 2011;118:3146-53.
22. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41-51.
23. Bilgic B, Pfefferbaum A, Rohlfing T, Sullivan EV, Adalsteinsson E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 2012;59:2625-35.
24. Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47:2089-111.
25. Huster D. Wilson disease. Best Pract Res Clin Gastroenterol 2010;24:531-9.
26. Sinha S, Taly AB, Ravishankar S, et al. Wilson's disease: cranial MRI observations and clinical correlation. Neuroradiology 2006;48:613-21.
27. Harder SL, Hopp KM, Ward H, Neglio H, Gitlin J, Kido D. Mineralization of the deep gray matter with age: a retrospective review with susceptibility weighted MR imaging. AJNR Am J Neuroradiol 2008;29:176-83.